In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swecure AB

www.swecure.com

Latest From Swecure AB

Biopharma In Sweden: A Comfortable Climate For Start-Ups

Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups.

BioPharmaceutical Sweden

Start-Up Previews, July-August 2014

This Month's Profile Groups: Biopharma In Sweden, features profiles of Northern Light Pharmaceuticals, Sigrid Therapeutics, and Swecure; ENT Devices features profiles of Aerin Medical, ENTvantage Diagnostics, Fiagon, and Spirox. Plus these Start-Ups Across Health Care: Anagnostics Bioanalysis, Check-Cap, Edico Genome, G1 Therapeutics, HeadSense Medical, Innovent Biologics, Navitor Pharmaceuticals, Onciomed, and RevMedx.

BioPharmaceutical Medical Device

Swecure AB

There are many treatments on the market and in development that ease the symptoms of allergies, from antihistamines to immunotherapies, but there is no real prevention or cure. Swedish biotech Swecure AB aims to prevent the development of allergies in the first place: its research is based on a bacterial protein, known as a superantigen, found in the gut flora of newborn babies.

BioPharmaceutical

Biopharma In Sweden: A Comfortable Climate For Start-Ups

Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups. Profiles of Northern Light Pharmaceuticals AB, Sigrid Therapeutics, and Swecure AB.

BioPharmaceutical Sweden
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Swecure AB
  • Senior Management
  • Lars Fahlen, CEO
    Alf Lindberg, MD, PhD, CSO
  • Contact Info
  • Swecure AB
    Phone: 70 247 89 88
    Stureplan 15
    Stockholm, SE-11145
    Sweden
Advertisement
Advertisement
UsernamePublicRestriction

Register